{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,14]],"date-time":"2026-03-14T06:51:02Z","timestamp":1773471062749,"version":"3.50.1"},"reference-count":15,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2014,10,1]],"date-time":"2014-10-01T00:00:00Z","timestamp":1412121600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,10,1]],"date-time":"2014-10-01T00:00:00Z","timestamp":1412121600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2015,12,2]],"date-time":"2015-12-02T00:00:00Z","timestamp":1449014400000},"content-version":"vor","delay-in-days":427,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001652","name":"Friedrich-Alexander-Universit\u00e4t Erlangen-N\u00fcrnberg","doi-asserted-by":"publisher","award":["ELAN-13-03-09-1-UH"],"award-info":[{"award-number":["ELAN-13-03-09-1-UH"]}],"id":[{"id":"10.13039\/501100001652","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["DFG 2163\/1-1"],"award-info":[{"award-number":["DFG 2163\/1-1"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jidonline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Investigative Dermatology"],"published-print":{"date-parts":[[2014,10]]},"DOI":"10.1038\/jid.2014.294","type":"journal-article","created":{"date-parts":[[2014,9,15]],"date-time":"2014-09-15T06:55:10Z","timestamp":1410764110000},"page":"2483-2485","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Complex Role of TNF Variants in Psoriatic Arthritis and Treatment Response to Anti-TNF Therapy: Evidence and Concepts"],"prefix":"10.1016","volume":"134","author":[{"given":"Ulrike","family":"H\u00fcffmeier","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rotraut","family":"M\u00f6ssner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1038\/jid.2014.294_bb0010","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1093\/bioinformatics\/bth457","article-title":"Haploview: analysis and visualization of LD and haplotype maps","volume":"21","author":"Barrett","year":"2005","journal-title":"Bioinformatics"},{"key":"10.1038\/jid.2014.294_bb0015","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1016\/j.humimm.2013.07.014","article-title":"Human leukocyte antigen alleles and susceptibility to psoriatic arthritis","volume":"74","author":"Chandran","year":"2013","journal-title":"Hum Immunol"},{"key":"10.1038\/jid.2014.294_bb0020","doi-asserted-by":"crossref","first-page":"e71690","DOI":"10.1371\/journal.pone.0071690","article-title":"An in-depth characterization of the major psoriasis susceptibility locus identifies candidate susceptibility alleles within an HLA-C enhancer element","volume":"8","author":"Clop","year":"2013","journal-title":"PLoS One"},{"key":"10.1038\/jid.2014.294_bb0025","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1046\/j.0306-5251.2001.01510.x","article-title":"Candidate gene case-control association studies: advantages and potential pitfalls","volume":"52","author":"Daly","year":"2001","journal-title":"Br J Clin Pharmacol"},{"key":"10.1038\/jid.2014.294_bb0030","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.semarthrit.2006.02.001","article-title":"Tumor necrosis factor antagonists: different kinetics and\/or mechanisms of action may explain differences in the risk for developing granulomatous infection","volume":"36","author":"Furst","year":"2006","journal-title":"Semin Arthritis Rheum"},{"key":"10.1038\/jid.2014.294_bb0035","doi-asserted-by":"crossref","first-page":"3801","DOI":"10.1002\/art.30591","article-title":"Tumor necrosis factor promoter polymorphism TNF*-857 is a risk allele for psoriatic arthritis independent of the PSORS1 locus","volume":"63","author":"Giardina","year":"2011","journal-title":"Arthritis Rheum"},{"key":"10.1038\/jid.2014.294_bb0040","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1038\/jid.2008.233","article-title":"Genetic variants of the IL-23R pathway: association with psoriatic arthritis and psoriasis vulgaris, but no specific risk factor for arthritis","volume":"129","author":"Huffmeier","year":"2009","journal-title":"J Invest Dermatol"},{"key":"10.1038\/jid.2014.294_bb0045","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1038\/ng.688","article-title":"Common variants at TRAF3IP2 are associated with susceptibility to psoriatic arthritis and psoriasis","volume":"42","author":"Huffmeier","year":"2010","journal-title":"Nat Genet"},{"key":"10.1038\/jid.2014.294_bb0050","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1038\/clpt.2013.197","article-title":"Treatment of BRAF-mutant melanoma: the role of vemurafenib and other therapies","volume":"95","author":"Jang","year":"2014","journal-title":"Clin Pharmacol Ther"},{"key":"10.1038\/jid.2014.294_bb0055","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1046\/j.1365-2370.2002.00273.x","article-title":"Association between two tumour necrosis factor intronic polymorphisms and HLA alleles","volume":"29","author":"Low","year":"2002","journal-title":"Eur J Immunogenet"},{"key":"10.1038\/jid.2014.294_bb0060","doi-asserted-by":"crossref","first-page":"2503","DOI":"10.1038\/jid.2014.123","article-title":"TNF-\u03b1 gene polymorphisms: association with disease susceptibility and response to anti-TNF-\u03b1 treatment in psoriatic arthritis","volume":"134","author":"Murdaca","year":"2014","journal-title":"J Invest Dermatol"},{"key":"10.1038\/jid.2014.294_bb0065","doi-asserted-by":"crossref","first-page":"2056","DOI":"10.1002\/art.22590","article-title":"TNF polymorphisms in psoriasis: association of psoriatic arthritis with the promoter polymorphism TNF*-857 independent of the PSORS1 risk allele","volume":"56","author":"Reich","year":"2007","journal-title":"Arthritis Rheum"},{"key":"10.1038\/jid.2014.294_bb0070","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1136\/annrheumdis-2012-202405","article-title":"Genome-wide association analysis of anti-TNF drug response in patients with rheumatoid arthritis","volume":"72","author":"Umicevic","year":"2013","journal-title":"Ann Rheum Dis"},{"key":"10.1038\/jid.2014.294_bb0075","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1136\/annrheumdis-2012-202407","article-title":"Long-term measurement of anti-adalimumab using pH-shift-anti-idiotype antigen binding test shows predictive value and transient antibody formation","volume":"72","author":"van Schouwenburg","year":"2013","journal-title":"Ann Rheum Dis"},{"key":"10.1038\/jid.2014.294_bb0080","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1038\/clpt.2012.189","article-title":"HLA genotype and carbamazepine-induced cutaneous adverse drug reactions: a systematic review","volume":"92","author":"Yip","year":"2012","journal-title":"Clin Pharmacol Ther"}],"container-title":["Journal of Investigative Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022202X15365131?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022202X15365131?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,4,6]],"date-time":"2025-04-06T21:08:24Z","timestamp":1743973704000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022202X15365131"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,10]]},"references-count":15,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2014,10]]}},"alternative-id":["S0022202X15365131"],"URL":"https:\/\/doi.org\/10.1038\/jid.2014.294","relation":{},"ISSN":["0022-202X"],"issn-type":[{"value":"0022-202X","type":"print"}],"subject":[],"published":{"date-parts":[[2014,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Complex Role of TNF Variants in Psoriatic Arthritis and Treatment Response to Anti-TNF Therapy: Evidence and Concepts","name":"articletitle","label":"Article Title"},{"value":"Journal of Investigative Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1038\/jid.2014.294","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 The Society for Investigative Dermatology, Inc. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}